Since autocrine regulation of HGF-Met is implicated in many forms of human
cancer, we investigated whether the predisposition to develop ovarian cance
r in women with hereditary ovarian cancer syndromes involves changes in the
expression of HGF-Met by the tissue of origin of epithelial ovarian cancer
s, the ovarian surface epithelium (OSE), We compared cultures of normal OSE
from women with (FH-OSE) (n = 20) and with no (NFH-OSE) (n = 48) family hi
stories of ovarian cancer, SV40 Tag immortalized OSE lines (IOSE, n = 5) an
d ovarian cancer cell lines (n = 3), Cultures derived from 21/22 women with
NFH-OSE and 13/13 women with FH-OSE expressed Met mRNA initially. After tw
o to three passages, Met was downregulated in 37% of NFH-OSE cultures but p
ersisted in 100% of FH-OSE cultures and ovarian cancer lines, like other ep
ithelial differentiation markers that are stabilized in FH-OSE and neoplasi
a, HGF and Met mRNA were concomitantly expressed by NFH-OSE from only three
of 32 women but in FH-OSE from eight of 13 women, and also in five of five
IOSE and two of three ovarian cancer lines. Conditioned media from FH-OSE,
but not NFH-OSE, contained immunoreactive HGF and induced cohort migration
which was inhibited by neutralizing HGF antibody. Several signaling molecu
les of the PI3K pathway, including Akt2 and p70 S6K, were constitutively ac
tivated in FH-OSE from six of six women but in NFH-OSE from only four of ei
ght women. Exogenous HGF was mitogenic in OSE, and that effect was regulate
d through the MAP kinase (ERK1/ERK2) and FRAP/p70 S6K pathways. The prolife
rative response to HGF was greater in NFH-OSE than in FH-OSE cultures. The
results show that FH-OSE cultures differ from NFH-OSE by increased stabilit
y of Met expression and by HGF secretion. Constitutive phosphorylation of k
inases and a diminished growth response to HGF suggest the presence of auto
crine regulation in FH-OSE. In analogy with other cell types where an autoc
rine HGF-R let loop has been implicated in tumorigenic transformation, this
change in FH-OSE may play a role in the enhanced susceptibility to ovarian
carcinogenesis in women with hereditary ovarian cancer syndromes.